Targeted therapy of pancreatic cancer: biomarkers are needed
- PMID: 28259609
- DOI: 10.1016/S1470-2045(17)30087-6
Targeted therapy of pancreatic cancer: biomarkers are needed
Comment on
-
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.Lancet Oncol. 2017 Apr;18(4):486-499. doi: 10.1016/S1470-2045(17)30084-0. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28259610 Clinical Trial.
Similar articles
-
Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.Expert Rev Proteomics. 2016;13(4):383-94. doi: 10.1586/14789450.2016.1167601. Expert Rev Proteomics. 2016. PMID: 26985644 Review.
-
Metabolomics in pancreatic cancer biomarkers research.Med Oncol. 2016 Dec;33(12):133. doi: 10.1007/s12032-016-0853-6. Epub 2016 Nov 2. Med Oncol. 2016. PMID: 27807722 Review.
-
PAK4 pathway as a potential therapeutic target in pancreatic cancer.Future Oncol. 2018 Mar;14(7):579-582. doi: 10.2217/fon-2017-0458. Epub 2018 Mar 6. Future Oncol. 2018. PMID: 29508632 Review. No abstract available.
-
Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?Expert Rev Proteomics. 2017 Jun;14(6):469-471. doi: 10.1080/14789450.2017.1314787. Epub 2017 Apr 17. Expert Rev Proteomics. 2017. PMID: 28388239 No abstract available.
-
Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy.J Hepatobiliary Pancreat Sci. 2012 Nov;19(6):614-20. doi: 10.1007/s00534-012-0547-1. J Hepatobiliary Pancreat Sci. 2012. PMID: 22878838 Review.
Cited by
-
WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness.Br J Cancer. 2020 Sep;123(6):1012-1023. doi: 10.1038/s41416-020-0929-0. Epub 2020 Jun 30. Br J Cancer. 2020. PMID: 32601462 Free PMC article.
-
Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways.Oxid Med Cell Longev. 2018 Mar 22;2018:9482018. doi: 10.1155/2018/9482018. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29765509 Free PMC article.
-
N-Dihydrogalactochitosan Potentiates the Radiosensitivity of Liver Metastatic Tumor Cells Originated from Murine Breast Tumors.Int J Mol Sci. 2019 Nov 8;20(22):5581. doi: 10.3390/ijms20225581. Int J Mol Sci. 2019. PMID: 31717306 Free PMC article.
-
Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer.Med Sci Monit. 2018 Jun 3;24:3720-3725. doi: 10.12659/MSM.909968. Med Sci Monit. 2018. PMID: 29860264 Free PMC article.
-
Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest.Mol Oncol. 2021 Feb;15(2):725-738. doi: 10.1002/1878-0261.12854. Epub 2020 Dec 12. Mol Oncol. 2021. PMID: 33226737 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical